Literature DB >> 8056185

Imbalance of the interleukin 2 system in children with IDDM.

T Tomoda1, T Kurashige, T Taniguchi.   

Abstract

The IL-2 system which involves IL-2 production, IL-2 receptor expression, and response to IL-2, is associated with autoimmune phenomena. Immunological abnormalities including autoimmune phenomena are believed to contribute to the pathogenesis of IDDM. In this study, the production of IL-2, the responses to IL-2 and IL-2 receptor expression by peripheral blood T lymphocytes were compared in IDDM and normal non-diabetic children. The percentage of IL-2 receptor-positive circulating T cells was significantly increased in diabetic children, although IL-2 receptor expression induced by con A stimulation did not differ in the diabetic and control children. IL-2 production was significantly decreased in diabetic children compared with the control children. The response of stimulated T cells to IL-2 did not differ in IDDM and control children. In IDDM, IL-2 production by CD4-positive T lymphocytes within the IL-2 system is thought to be selectively defective. On the other hand, IL-4, which is also produced by CD4-positive T lymphocytes, was increased. Since IL-4 did not suppress IL-2 production, it would seem that the IL-2 producing subset in CD4+HLA-DR+ T cells is decreased in IDDM. These results suggest that in recent onset IDDM, IL-2 receptor-positive circulating T cells require an IL-2 supply.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8056185     DOI: 10.1007/s001250050135

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  27 in total

1.  Depression in gene expression for poly(ADP-ribose) synthetase during the interferon-gamma-induced activation process of murine macrophage tumor cells.

Authors:  T Taniguchi; K Yamauchi; T Yamamoto; K Toyoshima; N Harada; H Tanaka; S Takahashi; H Yamamoto; S Fujimoto
Journal:  Eur J Biochem       Date:  1988-02-01

2.  Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies.

Authors:  G F Bottazzo; A Florin-Christensen; D Doniach
Journal:  Lancet       Date:  1974-11-30       Impact factor: 79.321

3.  T cell growth factor: parameters of production and a quantitative microassay for activity.

Authors:  S Gillis; M M Ferm; W Ou; K A Smith
Journal:  J Immunol       Date:  1978-06       Impact factor: 5.422

4.  IL-4 inhibits IL-2 synthesis and IL-2-induced up-regulation of IL-2R alpha but not IL-2R beta chain in CD4+ human T cells.

Authors:  A Gayá; O de la Calle; J Yagüe; E Alsinet; M D Fernández; M Romero; V Fabregat; J Martorell; J Vives
Journal:  J Immunol       Date:  1991-06-15       Impact factor: 5.422

Review 5.  Cellular origins and targets of costimulator (IL2).

Authors:  V Paetkau; J Shaw; G Mills; B Caplan
Journal:  Immunol Rev       Date:  1980       Impact factor: 12.988

6.  Structure and expression of a cloned cDNA for human interleukin-2.

Authors:  T Taniguchi; H Matsui; T Fujita; C Takaoka; N Kashima; R Yoshimoto; J Hamuro
Journal:  Nature       Date:  1983 Mar 24-30       Impact factor: 49.962

7.  Alterations of in vitro interleukin 1 and 2 in diabetic children.

Authors:  R Lorini; D Montagna; A Lanfranchi; L Cortona; C Livieri; D Larizza; G d'Annunzio; F Severi
Journal:  Eur J Pediatr       Date:  1989-08       Impact factor: 3.183

8.  Heterogeneity of helper/inducer T lymphocytes. II. Effects of interleukin 4- and interleukin 2-producing T cell clones on resting B lymphocytes.

Authors:  W H Boom; D Liano; A K Abbas
Journal:  J Exp Med       Date:  1988-04-01       Impact factor: 14.307

9.  Distinct functional phenotypes of cloned Ia-restricted helper T cells.

Authors:  J Kim; A Woods; E Becker-Dunn; K Bottomly
Journal:  J Exp Med       Date:  1985-07-01       Impact factor: 14.307

10.  Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice.

Authors:  M J Rapoport; A Jaramillo; D Zipris; A H Lazarus; D V Serreze; E H Leiter; P Cyopick; J S Danska; T L Delovitch
Journal:  J Exp Med       Date:  1993-07-01       Impact factor: 14.307

View more
  2 in total

Review 1.  The role of interleukin-1 in the pathogenesis of IDDM.

Authors:  T Mandrup-Poulsen
Journal:  Diabetologia       Date:  1996-09       Impact factor: 10.122

2.  Serum IL-1beta, IL-2, and IL-6 in insulin-dependent diabetic children.

Authors:  Yasar Dogan; Saadet Akarsu; Bilal Ustundag; Erdal Yilmaz; Metin Kaya Gurgoze
Journal:  Mediators Inflamm       Date:  2006       Impact factor: 4.711

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.